scholarly journals Assessment of psychosocial and demographic characteristics related to relapse in schizophrenic patients in psychiatric hospital of Assiut university.

2020 ◽  
Vol 8 (21) ◽  
pp. 25-33
Author(s):  
Rasha Abdel-Harse Amin ◽  
Ahmed Ahmed Abdel Bakey Abdel Rahman ◽  
Nadia Nadia Abd Elghany Abd Elhameed ◽  
Manal Abo Elil Abo Elghiet
Author(s):  
V. P. Kontaxakis ◽  
V. A. Protopappa ◽  
G. N. Christodoulou ◽  
B. J. Havaki-Kontaxaki

1995 ◽  
Vol 167 (6) ◽  
pp. 760-764 ◽  
Author(s):  
Moshe Avnon ◽  
Jonathan Rabinowitz

BackgroundClozapine's effectiveness in reducing symptoms and facilitating discharge among patients with chronic schizophrenia who were resistant to neuroleptics was studied.MethodAll 169 such patients in a public psychiatric hospital were given clozapine. BPRS ratings (0–5 scale) were completed before treatment and 21 months later. Patients were followed for about 2.5 years.ResultsClozapine was discontinued in 37.8% of cases due to non-compliance, non-response, or side-effects. At follow-up 41 % of clozapine recipients and 25.9% of the drop-outs were discharged and remained so, and 33% of recipients and 24.1% of drop-outs were being prepared for discharge. Longer treatment was associated with more improvement. Decline in average BPRS total scores of recipients was significantly more than drop-outs (32.7, s.d. 16.8 v. 12.1, s.d. 14.1, d.f. = 155, t = 7.5, P = 0.000).ConclusionsClozapine appears to be effective for treating some chronic neuroleptic non-responding schizophrenic patients.


2019 ◽  
Vol 30 (1) ◽  
pp. 19-23
Author(s):  
H Yusuf ◽  
A Giwa ◽  
S Mohammed ◽  
SN Aguye Abdu ◽  
FM Dungus ◽  
...  

Introduction: In clinical practice, it is required that a profession not only clearly describe their own roles and responsibilities to other professionals but should also be aware of other professions’ roles in relation to their own. The objective of this study was to assess the perceptions of physicians and allied health care workers (Other health care professionals) of the roles of pharmacists in optimizing care for schizophrenic patients. Methods: A self-administered 17-item validated questionnaire was distributed to 120 health care professionals working at Federal Neuro-Psychiatric Hospital Maiduguri from September to October 2016. Results obtained were analysed using Chi-square test. Results: Health care professionals mostly had positive perceptions with a statistically significant difference (P< 0.05) across all assessed items. However, competent and knowledge of the pharmacists accounting for 93 (83.8%), involvement of the pharmacist in patient care accounting for 91(82%) and reassuring patients to improve quality of life accounting for 98(88.3%) had the highest number of health care professionals with positive perceptions while documenting patient care, monitoring and reemphasizing physicians instructions had the lowest accounting for 69 (62.2%), 74(66.7%) and 74 (66.7%) respectively in the different sections. Conclusions: The health care professionals surveyed mostly had positive perceptions. Thus, pharmacists can leverage on this to meet their roles in optimizing care for schizophrenic patients. Bangladesh J Medicine Jan 2019; 30(1) : 19-23


1989 ◽  
Vol 155 (3) ◽  
pp. 352-355 ◽  
Author(s):  
J. C. Rigby ◽  
S. M. Wood ◽  
R. H. S. Mindham

The admission records of 271 long-stay chronic schizophrenic patients, resident in a large psychiatric hospital, were examined in order to identify those who had presented in stupor at the onset of their illness. Twelve patients were found (ten men and two women). When compared, in terms of current mental state and behaviour, with a similar sample of schizophrenics in whom stupor had been absent, significant differences between the two groups were detected, with those presenting in stupor demonstrating a less favourable outcome.


1979 ◽  
Vol 135 (1) ◽  
pp. 35-41 ◽  
Author(s):  
A. A. Robin ◽  
J. B. Copas ◽  
D. L. Freeman-Browne

SummaryTreatment in a psychiatric unit, as distinct from a psychiatric hospital, held no benefits in the long term (5–8 years after admission) as far as the patient's mental and behavioural status and employment, or the family's burdens, health needs or attitude were concerned. Schizophrenic patients from both settings received more hospital treatment and medication, were more often unemployed, and had more adverse effect on relatives' health than neurotic or depressive patients. Hospital attendence identified relatives who expressed a need for support.


1976 ◽  
Vol 42 (3) ◽  
pp. 944-946 ◽  
Author(s):  
Otto F. Wahl

26 schizophrenic patients (40 to 55 yr.), 21 non-schizophrenic patients (40 to 55 yr.), and 18 staff controls (25 to 40 yr.) from the same unit of a public psychiatric hospital were questioned about hand preference. Schizophrenics showed somewhat more confusion about hand preference than other subjects, but otherwise patterns of hand preference did not differ for the three groups. The inclusion of schizophrenics among those groups identified with laterality disturbances, then, was not supported.


2000 ◽  
Vol 17 (3) ◽  
pp. 91-95 ◽  
Author(s):  
Camilla Haw ◽  
Jean Stubbs ◽  
Christopher Mountjoy

AbstractObjectives: To audit the prescribing of clozapine for inpatients at a large, specialist psychiatric hospital.Method: The clinical standards used were agreed by the authors after reference to the clozapine data sheet and British National Formulary (BNF). Prescribing practices for forty-six patients were audited.Results: In this population of difficult to manage, treatment-resistant schizophrenic patients, prescribing and case note documentation needed improvement. Although almost all of these patients had had an adequate trial of clozapine monotherapy, over a quarter were currently receiving clozapine augmented with another antipsychotic. Plasma clozapine monitoring was used only once in a patient who had failed to respond adequately to clozapine.Conclusions: Clinicians should fully document the patient's consent to treatment, the clinical response to treatment and the reasons for any deviation in clinical practice from that recommended by the data sheet and national formulary. Plasma clozapine monitoring should be used to optimise therapy and clinical rating scales should be used to evaluate outcome. Until the clinical effectiveness of clozapine augmentation strategies is proven, their use should be restricted to cases where evidence-based therapies have failed.


2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
B. Han ◽  
R. Tang ◽  
H. Sun ◽  
S. Zhao ◽  
M. Xu

Aims:To compare efficacy and medical costs of typital and atypical antipsychotics in treating schizophrenic patients.Methods:250 in patients in general hospital and psychiatric hospital were randomly allocated to one of the two groups, one treated with typital antipsychotics as chlorpromazine, haloperidol and so on with a mean daily dose of 500∼800 mg in chlorpromazine equivalents, and the other with atypical agents in cluding clozapine (mean daily dose of 400∼800mg ), risperidone of 6 mg, or olanzapine of 20 mg.Results:The total costs of the treatment were (3157±253) Yuan RMB for patients treated with typical agents in general hospital, and (3673±294) Yuan RMB for patients treated with typical agents in psychiatric hospital respectively. the costs for medicine were (774±903) Yuan RMB, (1061±903) Yuan RMB respectively. the costs in atypical group were(1120±390) Yuan RMB and (1637±325) Yuan RMB, and (108±157) Yuan RMB and (240±317) Yuan RMB respectively. the duration of patients treated with typical agents in hospital is longer than that with atypical agents.Conclusions:It indicates that atypical antipsychotics have similar efficacy to typical agents in treating schizophrenic patients with less costs.


Sign in / Sign up

Export Citation Format

Share Document